Alzinova AB Namn-Aktier o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

79.25%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.02 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.042 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 05:02:33 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0450.03
PREV. DAY'S PRICE0.0296 (07/20)
CHANGE DAY BEFORE
+0.01
41.89 %
52 WEEK HIGH / LOW0.246 (10/06)0.0108 (06/05)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.03-0.03-0.02-0.02-0.03
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
1.212.490.71--
PRICE - SALES RATIO
455.43----
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2N87T
ISIN
SE0007413455
SYMBOL
78D
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
ALZINOVA AB
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-7.19 %
124.64 %
-29.55 %
-31.11 %
-79.25 %
-85.82 %
-95.04 %
-61.25 %
HIGH0.080.110.110.110.250.380.670.11
LOW0.030.010.010.010.010.010.010.01

Dividende

pro Aktie
ALZINOVA AB does not deliver dividend information

Company profile

Alzinova AB engages in the research and development of drugs for treatment of Alzheimer's disease. It focuses on the development of oligomer-directed vaccine and monoclonal antibody specifically for the synapse-damaging oligomers. The company was founded by Anders Sandberg and Thorleif Roland Hard on August 17, 2011 and is headquartered in Molndal, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.